Rentschler Biopharma SE, a global contract development and manufacturing organization for biopharmaceuticals, has appointed
Martin Kessler as CEO of Rentschler Biopharma Inc., the company’s wholly owned U.S. subsidiary, and as senior vice president transformation of Rentschler Biopharma SE.
Kessler brings more than 15 years of experience in pharmaceutical and biopharmaceutical operations and strategy. At Rentschler Biopharma, he will drive the transformation throughout the company as it grows strategically into new fields and technologies. In his role as head of the U.S. business, he will lead the ongoing expansion at the company’s Greater Boston area site, which includes expanding capabilities, capacity and talent.
The United States will ramp up its forces in Germany amid the latest tensions with Russia over Ukraine, abandoning former.
Beuth was a member of the Deutsche Tischgesellschaft, an antisemitic organization founded in Berlin in 1811. He publicly expressed his opposition to Jewish civic and political emancipation.
The university said that the decision to excise Beuth’s name was the fruit of three years of internal debate.
“We are a cosmopolitan university with students from 132 countries,” said its president, Werner Ullmann, following the a vote in favor of the name change by the university’s Academic Council. “Lived tolerance and diversity in studies, teaching and research and among the students are part of everyday life at our university.”